| Year |
Citation |
Score |
| 2018 |
Shah RM, Maize KM, West HT, Strom AM, Finzel BC, Wagner CR. Structure and Functional Characterization of Human Histidine Triad Nucleotide Binding Protein 1 Mutations Associated with Inherited Axonal Neuropathy with Neuromyotonia. Journal of Molecular Biology. PMID 29787766 DOI: 10.1016/J.Jmb.2018.05.028 |
0.65 |
|
| 2017 |
Maize KM, Shah R, Strom A, Kumarapperuma SC, Zhou AL, Wagner CR, Finzel BC. A Crystal Structure-Based Guide to the Design of Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) Activated ProTides. Molecular Pharmaceutics. PMID 28968488 DOI: 10.1021/Acs.Molpharmaceut.7B00664 |
0.701 |
|
| 2017 |
Shah R, Chou TF, Maize KM, Strom A, Finzel BC, Wagner CR. Inhibition by divalent metal ions of human histidine triad nucleotide binding protein1 (hHint1), a regulator of opioid analgesia and neuropathic pain. Biochemical and Biophysical Research Communications. PMID 28739258 DOI: 10.1016/J.Bbrc.2017.07.111 |
0.61 |
|
| 2017 |
Shah R, Maize KM, Zhou X, Finzel BC, Wagner CR. Caught before Released: Structural Mapping of the Reaction Trajectory for the Sofosbuvir Activating Enzyme, Human Histidine Triad Nucleotide Binding Protein 1 (hHint1). Biochemistry. PMID 28691797 DOI: 10.1021/Acs.Biochem.7B00148 |
0.682 |
|
| 2017 |
Liu F, Dawadi S, Maize KM, Dai R, Park SW, Schnappinger D, Finzel BC, Aldrich CC. Structure-Based Optimization of Pyridoxal 5'-Phosphate (PLP)-Dependent Transaminase Enzyme (BioA) Inhibitors that Target Biotin Biosynthesis in Mycobacterium tuberculosis. Journal of Medicinal Chemistry. PMID 28594172 DOI: 10.1021/Acs.Jmedchem.7B00189 |
0.704 |
|
| 2017 |
Eiden CG, Maize KM, Finzel BC, Lipscomb JD, Aldrich CC. Rational Optimization of Mechanism-Based Inhibitors through Determination of the Microscopic Rate Constants of Inactivation. Journal of the American Chemical Society. PMID 28510452 DOI: 10.1021/Jacs.7B00962 |
0.632 |
|
| 2017 |
Maize KM, Shah R, Strom A, Kumarapperuma S, Wagner CR, Finzel BC. A structure-based guide to building hHint-1 activated nucleotide prodrugs Acta Crystallographica Section a Foundations and Advances. 73: a300-a300. DOI: 10.1107/S0108767317097069 |
0.626 |
|
| 2016 |
Shah R, Strom A, Zhou A, Maize KM, Finzel BC, Wagner CR. Design, Synthesis, and Characterization of Sulfamide and Sulfamate Nucleotidomimetic Inhibitors of hHint1. Acs Medicinal Chemistry Letters. 7: 780-4. PMID 27563403 DOI: 10.1021/Acsmedchemlett.6B00169 |
0.663 |
|
| 2015 |
Maize KM, Kurbanov EK, Johnson RL, Amin EA, Finzel BC. Ligand-induced expansion of the S1' site in the anthrax toxin lethal factor. Febs Letters. PMID 26578066 DOI: 10.1016/J.Febslet.2015.11.005 |
0.682 |
|
| 2015 |
Kurbanov EK, Chiu TL, Solberg J, Francis S, Maize KM, Fernandez J, Johnson RL, Hawkinson JE, Walters MA, Finzel BC, Amin EA. Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates. Journal of Medicinal Chemistry. PMID 26492514 DOI: 10.1021/Acs.Jmedchem.5B01446 |
0.698 |
|
| 2014 |
Maize KM, Zhang X, Amin EA. Statistical analysis, optimization, and prioritization of virtual screening parameters for zinc enzymes including the anthrax toxin lethal factor. Current Topics in Medicinal Chemistry. 14: 2105-14. PMID 25373478 DOI: 10.2174/1568026614666141106163011 |
0.365 |
|
| 2014 |
Maize KM, Kurbanov EK, De La Mora-Rey T, Geders TW, Hwang DJ, Walters MA, Johnson RL, Amin EA, Finzel BC. Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding. Acta Crystallographica. Section D, Biological Crystallography. 70: 2813-22. PMID 25372673 DOI: 10.1107/S1399004714018161 |
0.644 |
|
| 2013 |
Maize KM, Wagner CR, Finzel BC. Structural characterization of human histidine triad nucleotide-binding protein 2, a member of the histidine triad superfamily. The Febs Journal. 280: 3389-98. PMID 23659632 DOI: 10.1111/Febs.12330 |
0.685 |
|
| 2013 |
Chiu TL, Maize KM, Amin EA. Identification of novel anthrax toxin countermeasures using in silico methods. Methods in Molecular Biology (Clifton, N.J.). 993: 177-84. PMID 23568471 DOI: 10.1007/978-1-62703-342-8_12 |
0.371 |
|
| Show low-probability matches. |